Bearish flow noted in Apellis Pharmaceuticals with 2,161 puts trading, or 3x expected. Most active are Oct-23 46 puts and Oct-23 44 puts, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 5.73, while ATM IV is up over 2 points on the day. Earnings are expected on November 6th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on APLS:
- Biotech Alert: Searches spiking for these stocks today
- Apellis Pharmaceuticals call volume above normal and directionally bullish
- Apellis price target raised to $46 from $44 at BofA
- ‘There’s Good Value in the Market Now’: J.P. Morgan Suggests 2 Stocks to Buy — Including One With 80% Upside
- JP Morgan Upgrades Apellis (NASDAQ:APLS) after Impressive Q3 Results